Jing Lin
Research Subjects
Research Interests
Jing Lin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Bi-Yun Feng
Fujian Provincial Key Laboratory of Biochemical Technology, Huaqiao University, Xiamen 361021, Fujian Province, PR China
1 shared publication - Dong-Yuan Zhang
Xiamen Medicine Research Institute, Xiamen, Fujian province, 361008, PR China
1 shared publication - Feng-Yan Qiu
Department of Respiratory and Critical Care Medicine, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou City Jiangsu Province 213000, China
1 shared publication - Guang-Hui Xu
Xiamen Medicine Research Institute, Xiamen, 361008, Fujian province, PR China
1 shared publication - Hui Yang
Xiamen Medicine Research Institute, Xiamen, Fujian province, 361008, PR China
1 shared publication - Hui Zhang
School of Pharmacy Faculty of Medicine Macau University of Science and Technology Macau 999078 China must.edu.mo
1 shared publication
Latest Publications
- 3 January 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (2) , 1331-1344
Examination of the Bioavailability and Bioconversion of Wheat Bran-Bound Ferulic Acid: Insights into Gastrointestinal Processing and Colonic Metabolites
The postingestion journey and bioconversion of wheat bran-bound ferulic acid, a known beneficial phytochemical, remain insufficiently understood. This study aims to systematically investigate its bioaccessibility, bioavailability, excretion, and colonic metabolism, both in vitro and in vivo. Initial analysis confirmed the abundance and bioactivity of ferulic acid in wheat bran. Using a simulated gastrointestinal model, 1.7% of the ferulic acid was found to be bioaccessible, in contrast to 43.4% for total phenolics. In vivo bioavailability was assessed in rats via oral gavage of cooked wheat bran, with a plasma ferulic acid level peaking at 32.5 ± 4.9 ng/mL, corresponding to an absorption rate of 0.3%, while 1% was excreted in urine. Fecal metabolomic analysis revealed extensive colonic bioconversion, with elevated levels of ferulic acid and its metabolites, including 3-phenylpropionic acid, dihydroferulic acid, 5-hydroxyferulic acid, and hippuric acid. Novel metabolites, such as 3-(2,5-dimethoxyphenyl)propionic acid and N-(2-furoyl)glycine, were detected for the first time. These findings shed light on the complex biotransformation of wheat bran-bound ferulic acid and its potential health implications.
- 3 January 2025
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 73 (2) , 1331-1344
Examination of the Bioavailability and Bioconversion of Wheat Bran-Bound Ferulic Acid: Insights into Gastrointestinal Processing and Colonic Metabolites
The postingestion journey and bioconversion of wheat bran-bound ferulic acid, a known beneficial phytochemical, remain insufficiently understood. This study aims to systematically investigate its bioaccessibility, bioavailability, excretion, and colonic metabolism, both in vitro and in vivo. Initial analysis confirmed the abundance and bioactivity of ferulic acid in wheat bran. Using a simulated gastrointestinal model, 1.7% of the ferulic acid was found to be bioaccessible, in contrast to 43.4% for total phenolics. In vivo bioavailability was assessed in rats via oral gavage of cooked wheat bran, with a plasma ferulic acid level peaking at 32.5 ± 4.9 ng/mL, corresponding to an absorption rate of 0.3%, while 1% was excreted in urine. Fecal metabolomic analysis revealed extensive colonic bioconversion, with elevated levels of ferulic acid and its metabolites, including 3-phenylpropionic acid, dihydroferulic acid, 5-hydroxyferulic acid, and hippuric acid. Novel metabolites, such as 3-(2,5-dimethoxyphenyl)propionic acid and N-(2-furoyl)glycine, were detected for the first time. These findings shed light on the complex biotransformation of wheat bran-bound ferulic acid and its potential health implications.